Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence Des évènements cArdiovasculaires majeurS Chez Les Patients COronariens diabétiques Subissant Une angioPlastie Coronaire et traités Par Clopidogrel à la Dose 150 mg Versus 75 mg

NCT03329261 is registered in ClinicalTrials.gov with Laboratoires Teriak as lead sponsor.

NCT NCT03329261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03329261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence Des évènements cArdiovasculaires majeurS Chez Les Patients COronariens diabétiques Subissant Une angioPlastie Coronaire et traités Par Clopidogrel à la Dose 150 mg Versus 75 mg
Lead sponsor
Laboratoires Teriak
Phase
Phase 4
Overall status
Completed
Start date
December 7, 2017
Completion date
December 20, 2019
Enrollment
167 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary angioplasty, diabetes mellitus, type 2, nstemi - non-st segment elevation mi